|
1
|
Bonavia R, Inda MM, Cavenee WK and Furnari
FB: Heterogeneity maintenance in glioblastoma: A social network.
Cancer Res. 71:4055–4060. 2011. View Article : Google Scholar
|
|
2
|
Hou LC, Veeravagu A, Hsu AR and Tse VC:
Recurrent glioblastoma multiforme: A review of natural history and
management options. Neurosurgical Focus. 20:E52006. View Article : Google Scholar
|
|
3
|
Gray S, Pandha HS, Michael A, Middleton G
and Morgan R: HOX genes in pancreatic development and cancer. JOP.
12:216–219. 2011.
|
|
4
|
Scott MP: A rational nomenclature for
vertebrate homeobox (HOX) genes. Nucleic Acids Res. 21:1687–1688.
1993. View Article : Google Scholar
|
|
5
|
Scott MP: Vertebrate homeobox gene
nomenclature. Cell. 71:551–553. 1992. View Article : Google Scholar
|
|
6
|
Levine M and Hoey T: Homeobox proteins as
sequence-specific transcription factors. Cell. 55:537–540. 1988.
View Article : Google Scholar
|
|
7
|
Calvo R, West J, Franklin W, Erickson P,
Bemis L, Li E, Helfrich B, Bunn P, Roche J, Brambilla E, et al:
Altered HOX and WNT7A expression in human lung cancer. Proc Natl
Acad Sci USA. 97:pp. 12776–12781. 2000; View Article : Google Scholar
|
|
8
|
Hung YC, Ueda M, Terai Y, Kumagai K, Ueki
K, Kanda K, Yamaguchi H, Akise D and Ueki M: Homeobox gene
expression and mutation in cervical carcinoma cells. Cancer Sci.
94:4372003. View Article : Google Scholar
|
|
9
|
Cantile M, Pettinato G, Procino A,
Feliciello I, Cindolo L and Cillo C: In vivo expression of the
whole HOX gene network in human breast cancer. Eur J Cancer.
39:257–264. 2003. View Article : Google Scholar
|
|
10
|
Vider BZ, Zimber A, Chastre E, Gespach C,
Halperin M, Mashiah P, Yaniv A and Gazit A: Deregulated expression
of homeobox-containing genes, HOXB6, B8, C8, C9, and Cdx-1, in
human colon cancer cell lines. Biochem Biophys Res Commun.
272:513–518. 2000. View Article : Google Scholar
|
|
11
|
Friedmann Y, Daniel CA, Strickland P and
Daniel CW: Hox genes in normal and neoplastic mouse mammary gland.
Cancer Res. 54:5981–5985. 1994.
|
|
12
|
Chen J, Zhu S, Jiang N, Shang Z, Quan C
and Niu Y: HoxB3 promotes prostate cancer cell progression by
transactivating CDCA3. Cancer Lett. 330:217–224. 2013. View Article : Google Scholar
|
|
13
|
Bodey B, Bodey B Jr, Gröger AM, Siegel SE
and Kaiser HE: Immunocytochemical detection of homeobox B3, B4, and
C6 gene product expression in lung carcinomas. Anticancer Res.
20:2711–2716. 2000.
|
|
14
|
Blaschuk OW and Devemy E: Cadherins as
novel targets for anti-cancer therapy. Eur J Pharmacol.
625:195–198. 2009. View Article : Google Scholar
|
|
15
|
Palakurthy RK, Wajapeyee N, Santra MK,
Gazin C, Lin L, Gobeil S and Green MR: Epigenetic silencing of the
RASSF1A tumor suppressor gene through HOXB3-mediated induction of
DNMT3B expression. Mol Cell. 36:219–230. 2009. View Article : Google Scholar
|
|
16
|
Chen H, Fan Y, Xu W, Chen J, Xu C, Wei X,
Fang D and Feng Y: miR-10b inhibits apoptosis and promotes
proliferation and invasion of endometrial cancer cells via
targeting HOXB3. Cancer Biother Radiopharm. 31:225–231. 2016.
View Article : Google Scholar
|
|
17
|
Almeida MI, Nicoloso MS, Zeng L, Ivan C,
Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, et al:
Strand-specific miR-28-5p and miR-28-3p have distinct effects in
colorectal cancer cells. Gastroenterology. 142:886–896.e9. 2012.
View Article : Google Scholar
|
|
18
|
Mikheeva SA, Mikheev AM, Petit A, Beyer R,
Oxford RG, Khorasani L, Maxwell JP, Glackin CA, Wakimoto H,
González-Herrero I, et al: TWIST1 promotes invasion through
mesenchymal change in human glioblastoma. Mol Cancer. 9:1942010.
View Article : Google Scholar
|
|
19
|
Cheng WY, Kandel JJ, Yamashiro DJ, Canoll
P and Anastassiou D: A multi-cancer mesenchymal transition gene
expression signature is associated with prolonged time to
recurrence in glioblastoma. PLoS One. 7:e347052012. View Article : Google Scholar
|
|
20
|
Kotelevets L, Van-Hengel J, Bruyneel E,
Mareel M, Van-Roy F and Chastre E: The lipid phosphatase activity
of PTEN is critical for stabilizing intercellular junctions and
reverting invasiveness. J Cell Biol. 155:1129–1135. 2001.
View Article : Google Scholar
|
|
21
|
Xia M, Hu M, Wang J, Xu Y, Chen X, Ma Y
and Su L: Identification of the role of Smad interacting protein 1
(SIP1) in glioma. J Neurooncol. 97:225–232. 2010. View Article : Google Scholar
|
|
22
|
Asano K, Duntsch CD, Zhou Q, Weimar JD,
Bordelon D, Robertson JH and Pourmotabbed T: Correlation of
N-cadherin expression in high grade gliomas with tissue invasion. J
Neurooncol. 70:3–15. 2004. View Article : Google Scholar
|
|
23
|
Motta FJ, Valera ET, Lucio-Eterovic AK,
Queiroz RG, Neder L, Scrideli CA, Machado HR, Carlotti-Junior CG,
Marie SK and Tone LG: Differential expression of E-cadherin gene in
human neuroepithelial tumors. Genet Mol Res. 7:295–304. 2008.
View Article : Google Scholar
|
|
24
|
Lu KV, Chang JP, Parachoniak CA, Pandika
MM, Aghi MK, Meyronet D, Isachenko N, Fouse SD, Phillips JJ,
Cheresh DA, et al: VEGF inhibits tumor cell invasion and
mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell.
22:21–35. 2012. View Article : Google Scholar
|
|
25
|
Weiss FU, Marques IJ, Woltering JM,
Vlecken DH, Aghdassi A, Partecke LI, Heidecke CD, Lerch MM and
Bagowski CP: Retinoic acid receptor antagonists inhibit mir-10a
expression and block metastatic behavior of pancreatic cancer.
Gastroenterology. 137:2136–2145.e1-7. 2009. View Article : Google Scholar
|
|
26
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar
|
|
27
|
Hanahan D and Weinberg R: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar
|
|
28
|
Kahlert UD, Nikkhah G and Maciaczyk J:
Epithelial-to-mesenchymal(-like) transition as a relevant molecular
event in malignant gliomas. Cancer Lett. 331:131–138. 2013.
View Article : Google Scholar
|
|
29
|
Kahlert UD, Maciaczyk D, Doostkam S, Orr
BA, Simons B, Bogiel T, Reithmeier T, Prinz M, Schubert J,
Niedermann G, et al: Activation of canonical WNT/β-catenin
signaling enhances in vitro motility of glioblastoma cells by
activation of ZEB1 and other activators of
epithelial-to-mesenchymal transition. Cancer Lett. 325:42–53. 2012.
View Article : Google Scholar
|
|
30
|
Svingen T and Tonissen KF: Altered HOX
gene expression in human skin and breast cancer cells. Cancer Biol
Ther. 2:518–523. 2003. View Article : Google Scholar
|
|
31
|
Shah N and Sukumar S: The Hox genes and
their roles in oncogenesis. Nat Rev Cancer. 10:361–371. 2010.
View Article : Google Scholar
|
|
32
|
Calvo KR, Sykes DB, Pasillas MP and Kamps
MP: Nup98-HoxA9 immortalizes myeloid progenitors, enforces
expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific
responses in a manner similar to that induced by retroviral
co-expression of Hoxa9 and Meis1. Oncogene. 21:4247–4256. 2002.
View Article : Google Scholar
|
|
33
|
Zhang X, Hamada J, Nishimoto A, Takahashi
Y, Murai T, Tada M and Moriuchi T: HOXC6 and HOXC11 increase
transcription of S100beta gene in BrdU-induced in vitro
differentiation of GOTO neuroblastoma cells into Schwannian cells.
J Cell Mol Med. 11:299–306. 2007. View Article : Google Scholar
|
